Form 4 Tracker
Sionna Therapeutics, Inc.
SION

5 insider filings · Latest: May 27, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 27, 2026May 30 1:02 AMPeter A. ThompsonDirector
Sale
101$44.49$4.5K2,671,721(I)

View →

May 27, 2026May 30 12:57 AMORBIMED ADVISORS LLCDirector
Sale
101$44.49$4.5K2,671,721(I)

View →

May 11, 2026May 11 11:14 PMPeter A. ThompsonDirector
Sale
184,639$46.22$8.5M2,671,822(I)

View →

May 8, 2026May 11 11:14 PMPeter A. ThompsonDirector
Sale
59,767$44.58$2.7M2,856,461(I)

View →

May 7, 2026May 11 11:14 PMPeter A. ThompsonDirector
Sale
48,546$44.61$2.2M2,916,228(I)

View →

May 11, 2026May 11 10:58 PMORBIMED ADVISORS LLCDirector
Sale
184,639$46.22$8.5M2,671,822(I)

View →

May 8, 2026May 11 10:58 PMORBIMED ADVISORS LLCDirector
Sale
59,767$44.58$2.7M2,856,461(I)

View →

May 7, 2026May 11 10:58 PMORBIMED ADVISORS LLCDirector
Sale
48,546$44.61$2.2M2,916,228(I)

View →

Mar 5, 2026Mar 6 11:56 PMJennifer FitzpatrickChief Legal Officer
Sale
10,250$33.86$347.0K0(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 5, 2026Mar 6 11:56 PMJennifer FitzpatrickChief Legal Officer
Option Exercise
10,250$6.1150,935(D)

View →